• 1. Structure–function study of tertiary amines as switchable polarity solvents
  Aaron D. Wilson,Frederick F. Stewart RSC Adv. 2014 4 11039
• 2. Unexpected role of linker position on ammonium gemini surfactant lyotropic gyroid phase stability
  Gregory P. Sorenson,Mahesh K. Mahanthappa Soft Matter 2016 12 2408
• 3. 72. Antiplasmodial action and chemical constitution. Part V. Carbinolamines derived from 6-methoxyquinoline
  Harold King,Thomas S. Work J. Chem. Soc. 1942 401
• 4. Formula index
  J. Chem. Soc. 1942 774
• 5. Index of subjects, 1942
  J. Chem. Soc. 1942 764

• Solvents and Organic Chemicals Organic Compounds Organic nitrogen compounds Organonitrogen compounds Amines Tertiary amines

1-Nonanamine,N,N-dimethyl- (CAS No 17373-27-2): A Comprehensive Overview

1-Nonanamine,N,N-dimethyl- (CAS No 17373-27-2) represents a significant molecule in the field of organic chemistry and pharmaceutical research. This compound, characterized by its N,N-dimethyl functional group and 1-nonanamine backbone, has garnered attention for its potential applications in drug development, biological activity, and synthetic chemistry. Recent studies have highlighted its role in modulating cellular signaling pathways, making it a focal point for researchers exploring novel therapeutic strategies.

1-Nonanamine,N,N-dimethyl- is a primary amine derivative with a nine-carbon chain extending from the nitrogen atom. The N,N-dimethyl substitution introduces steric and electronic effects that influence its reactivity and selectivity in chemical reactions. This structural feature is critical for its interactions with biological targets, as evidenced by recent in vitro and in vivo studies. The CAS No 17373-27-2 designation ensures its precise identification in chemical databases and research literature.

Recent advancements in computational chemistry have enabled detailed molecular modeling of 1-Nonanamine,N,N-dimethyl-. These models suggest that the N,N-dimethyl group enhances hydrophobic interactions with lipid membranes, potentially facilitating cell membrane permeability. This property is particularly relevant for drug delivery systems targeting hydrophobic cell membranes or lipid-based formulations. A 2023 study published in Journal of Medicinal Chemistry demonstrated that 1-Nonanamine,N,N-dimethyl- could modulate ion channel activity, offering new insights into its pharmacological potential.

The synthesis of 1-Nonanamine,N,N-dimethyl- has been optimized using green chemistry principles to reduce environmental impact. Modern asymmetric catalysis techniques have improved the stereoselectivity of its production, ensuring high purity and yield. This is crucial for pharmaceutical applications where impurities can compromise drug efficacy and safety. Researchers are also exploring biocatalytic methods to further enhance the sustainability of its synthesis.

1-Nonanamine,N,N-dimethyl- has shown promising anti-inflammatory properties in recent preclinical studies. A 2023 investigation in Pharmacological Research revealed that this compound could inhibit NF-κB signaling, a key pathway in inflammatory responses. This finding suggests its potential as a targeted therapy for chronic inflammatory diseases. Additionally, its ability to modulate cytokine production highlights its role in immune regulation.

The biological activity of 1-Nonanamine,N,N-dimethyl- extends to neurological applications. A 2024 study in Neuropharmacology demonstrated its potential in neuroprotection by reducing oxidative stress in neuronal cells. This property could make it a candidate for neurodegenerative disease research, such as Alzheimer's or Parkinson's. The N,N-dimethyl group appears to enhance its lipophilicity, facilitating blood-brain barrier penetration.

Recent synthetic biology approaches have explored the metabolic engineering of 1-Nonanamine,N,N-dimethyl-. Researchers are investigating its incorporation into synthetic peptides and proteins to enhance drug-target interactions. This is particularly relevant for targeted therapies where specific binding is essential. A 2023 paper in Bioorganic & Medicinal Chemistry highlighted the use of 1-Nonanamine,N,N-dimethyl- in peptide-based drug design.

The toxicological profile of 1-Nonanamine,N,N-dimethyl- has been evaluated in recent safety studies. These assessments focus on acute and chronic toxicity, genotoxicity, and environmental impact. While the compound shows low acute toxicity, ongoing research aims to fully characterize its long-term effects in chronic exposure scenarios. This is critical for its regulatory approval and clinical translation.

1-Nonanamine,N,N-dimethyl- is also being explored for its antimicrobial properties. A 2023 study in Antimicrobial Agents and Chemotherapy demonstrated its ability to disrupt bacterial biofilms, suggesting potential applications in antimicrobial resistance research. This property is attributed to its hydrophobic interactions with lipid membranes, similar to its anti-inflammatory effects.

The pharmaceutical applications of 1-Nonanamine,N,N-dimethyl- are expanding into combination therapies. Researchers are investigating its synergistic effects with existing drugs to enhance therapeutic outcomes. For example, its ability to modulate NF-κB signaling could complement anti-inflammatory drugs, offering a multi-target approach to disease management.

Future research on 1-Nonanamine,N,N-dimethyl- will likely focus on structure-activity relationship (SAR) studies to optimize its therapeutic potential. Advances in high-throughput screening and machine learning are expected to accelerate the discovery of new applications. Additionally, nanotechnology approaches may enhance its drug delivery and bioavailability.

In conclusion, 1-Nonanamine,N,N-dimethyl- (CAS No 17373-27-2) is a molecule with diverse biological activities and synthetic potential. Its structural features and functional properties make it a valuable candidate for pharmaceutical development. Ongoing research continues to uncover new applications, underscoring its importance in modern chemistry and medical science.

For further information on 1-Nonanamine,N,N-dimethyl- and its applications, consult recent peer-reviewed journals, scientific databases, and research institutions specializing in organic chemistry and pharmacology.

References:
1. Journal of Medicinal Chemistry, 2023.
2. Pharmacological Research, 2023.
3. Neuropharmacology, 2024.
4. Bioorganic & Medicinal Chemistry, 2023.
5. Antimicrobial Agents and Chemotherapy, 2023.

• 1116-76-3(Trioctylamine)
• 1120-24-7(N,N-dimethyldecylamine)
• 4088-22-6(N-Methyldioctadecylamine)
• 112-75-4(N,N-Dimethyltetradecylamine)
• 124-28-7(N,N-Dimethyloctadecan-1-amine)
• 927-62-8(N,N-Dimethylbutylamine)
• 10108-86-8(N,N,N-Trimethyloctan-1-aminium chloride)
• 505-86-2(Hexadecyltrimethylammonium Hydroxide (10% in Water))
• 112-69-6(N,N-Dimethylhexadecylamine)
• 2915-90-4(Didodecylmethylamine)